TMBIM6 and prostate cancer: While downregulation of BI-1 has been shown to induce apoptosis in human nasopharyngeal carcinoma cell lines [22,23] and reduce cell viability in prostate cancer cells [24], no small-molecule drugs specifically targeting BI-1 have been identified thus far.